Prof. Dr. Sarah Lippe currently works as a FRQ-S Scientist and co-Head Deputy of the Brain and Child Development axis at the CHU Sainte-Justine Hospital and Full Professor at the Psychology Department of the University of Montreal, and member of several research groups and networks (BRAMS, CerebrUM, GRIP, TACC, KBHN). She completed a Master’s degree in neuropsychology and a Ph.D. in clinical and research neuropsychology at the University of Montreal. She was trained as a postdoctoral fellow in neuroscience at the Atomic Energy Commission (France) and at the Baycrest Centre for Geriatric Care (Toronto). Her research focuses on brain development, sensory processing and sensitivity and learning in healthy infants and children. Further, she investigates neurodevelopmental disorders risk factors. She particularly wants to understand the prenatal and genetic risk factors leading to neurodevelopmental disorders, and their consequences on brain development, sensory processing and sensitivity and learning capacities. Her investigation methods are non-invasive and enables her to develop early screening methods and treatment efficacy assessments.
Prof. Dr. Sarah Lippe currently works as a FRQ-S Scientist and co-Head Deputy of the Brain and Child Development axis at the CHU Sainte-Justine Hospital and Full Professor at the Psychology Department of the University of Montreal, and member of several research groups and networks (BRAMS, CerebrUM, GRIP, TACC, KBHN). She completed a Master’s degree in neuropsychology and a Ph.D. in clinical and research neuropsychology at the University of Montreal. She was trained as a postdoctoral fellow in neuroscience at the Atomic Energy Commission (France) and at the Baycrest Centre for Geriatric Care (Toronto). Her research focuses on brain development, sensory processing and sensitivity and learning in healthy infants and children. Further, she investigates neurodevelopmental disorders risk factors. She particularly wants to understand the prenatal and genetic risk factors leading to neurodevelopmental disorders, and their consequences on brain development, sensory processing and sensitivity and learning capacities. Her investigation methods are non-invasive and enables her to develop early screening methods and treatment efficacy assessments.